TMO vs MRNA
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Moderna, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | MRNA |
|---|---|---|
| Price | $675.00 | $198.88 |
| Market cap | $249.58B | $79.40B |
| P/E ratio | 36.4 | — |
| ROE | 13.51% | -39.00% |
| Profit margin | 15.04% | -141.43% |
| Revenue growth | 10.50% | 2.10% |
| Dividend yield | 0.28% | — |
| Beta | 0.85 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs MRNA in plain English
- TMO is the bigger company — about 3.1× the market cap of MRNA.
- TMO earns a higher return on equity (14% vs -39%).
- TMO is growing revenue faster (10% vs 2%).
- TMO pays a dividend (0.28%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
MRNA return calculator
See what $1,000 in Moderna, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.